Clovis Oncology, Inc. filed a motion in the US Bankruptcy Court seeking the extension of its exclusivity periods on April 10, 2023. As per the motion, the debtor seeks to extend its exclusivity periods for both, to file a plan and to solicit votes on a plan, by 90 days i.e. up to July 10, 2023 and September 11, 2023, respectively. The debtor's current exclusivity period and solicitation period would expire on April 10, 2023 and June 9, 2023, respectively.